Adults who have colorectal cancer may receive regorafenib (Stivarga®), a chemotherapy medication that is reserved for use when the cancer has progressed following other chemotherapy treatment. The medication comes in the form of a tablet that is taken once daily in the morning.
Bayer HealthCare Pharmaceuticals, Inc., manufactures brand-name regorafenib, sold under the name Stivarga. Although regorafenib is sometimes referred to as the "generic name" for Stivarga, it is simply the active ingredient in the drug and not a generic version of it. There are currently no generic versions of regorafenib available, due to certain patents that have not yet expired.
(Click Regorafenib for more in-depth information on using regorafenib for treating colorectal cancer. This article also offers detailed information on how this drug works, possible side effects, and more.)